Evidence map›Paper›PMID 14724742›Full record

ArticleThe Journal of membrane biology2003

Endothelial cell swelling by aldosterone.

H Oberleithner, S W Schneider, L Albermann, U Hillebrand, T Ludwig, C Riethmüller, V Shahin, C Schäfer, H Schillers

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in The Journal of membrane biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Salt controls endothelial and vascular phenotype.Pflugers Archiv : European journal of physiology · 2015
    Review
  8. The role of ENaC in vascular endothelium.Pflugers Archiv : European journal of physiology · 2014
    Review
  9. Nanomechanics of vascular endothelium.Cell and tissue research · 2014
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Nitric oxide release follows endothelial nanomechanics and not vice versa.Pflugers Archiv : European journal of physiology · 2010
    Article
  16. Article
  17. Review
  18. Review
  19. Aldosterone and amiloride alter ENaC abundance in vascular endothelium.Pflugers Archiv : European journal of physiology · 2008
    Article
  20. Underexpression of mineralocorticoid receptor in colorectal carcinomas and association with VEGFR-2 overexpression.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

H OberleithnerInstitute of Physiology I, Nanolab, University of Münster, Robert-Koch-Str. 27a, D-48149 Münster, Germany. oberlei@uni-muenster.de
S W Schneider
L Albermann
U Hillebrand
T Ludwig
C Riethmüller
V Shahin
C Schäfer
H Schillers
University of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is accumulating evidence that mineralocorticoids not only act on kidney but also on the cardiovascular system. We investigated the response of human umbilical venous endothelial cells (HUVECs) to aldosterone at a time scale of 20 minutes in absence and presence of the aldosterone antagonist spironolactone or other transport inhibitors. We applied atomic force microscopy (AFM), which measures cell volume and volume shifts between cytosol and cell nucleus. We observed an immediate cell volume increase (about 10%) approximately 1 min after addition of aldosterone (0.1 micromol/l), approaching a maximum (about 18%) 10 min after aldosterone treatment. Cell volume returned to normal 20 min after hormone exposure. Spironolactone (1 micromol/l) or amiloride (1 micromol/l) prevented the late aldosterone-induced volume changes but not the immediate change observed 1 min after hormone exposure. AFM revealed nuclear swelling 5 min after aldosterone addition, followed by nuclear shrinkage 15 min later. The Na(+)/H(+) exchange blocker cariporide (10 micromol/l) was ineffective. We conclude: (i). Aldosterone induces immediate (1 min) swelling independently of plasma membrane Na(+) channels and intracellular mineralocorticoid receptors followed by late mineralocorticoid receptor- and Na(+)-channel-dependent swelling. (ii). Intracellular macromolecule shifts cause the changes in cell volume. (iii). Both amiloride and spironolactone may be useful for medical applications to prevent aldosterone-induced vasculopathies.

Indexed as

Adaptation, PhysiologicalAldosteroneCell Membrane PermeabilityCells, CulturedCell SizeEndothelial CellsHumansNuclear EnvelopeReceptors, MineralocorticoidSpironolactoneUmbilical VeinsWater-Electrolyte BalanceAldosteroneReceptors, MineralocorticoidSpironolactone

Identifiers

PMID14724742
OpenAlexW2171331990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.